Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,666 | -17,704 | -2,318 | -908 | 3,112 |
| Depreciation Amortization | 715 | 353 | 1,300 | 763 | 490 |
| Accounts receivable | -3,537 | -1,830 | -1,063 | -1,356 | -7,586 |
| Other Working Capital | -4,489 | -3,397 | 6,933 | 4,969 | 2,511 |
| Other Operating Activity | 2,246 | 13,529 | -28,531 | -21,499 | -9,035 |
| Operating Cash Flow | $-14,731 | $-9,049 | $-23,679 | $-18,031 | $-10,508 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -143 | -9 | -1,178 | -973 | -676 |
| Purchase Sale Intangibles | -498 | -253 | -1,127 | -548 | -525 |
| Other Investing Activity | -498 | -253 | -1,127 | -548 | -525 |
| Investing Cash Flow | $-641 | $-262 | $-2,305 | $-1,521 | $-1,201 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -42 | -21 | -81 | -61 | -40 |
| Common Stock Issued | 1 | 1 | 32,380 | 32,380 | 32,348 |
| Financing Cash Flow | $-41 | $-20 | $32,299 | $32,319 | $32,308 |
| Beginning Cash Position | 39,904 | 39,904 | 33,589 | 33,589 | 33,589 |
| End Cash Position | 24,491 | 30,573 | 39,904 | 46,356 | 54,188 |
| Net Cash Flow | $-15,413 | $-9,331 | $6,315 | $12,767 | $20,599 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,731 | -9,049 | -23,679 | -18,031 | -10,508 |
| Capital Expenditure | -143 | -9 | -1,178 | -973 | -676 |
| Free Cash Flow | -14,874 | -9,058 | -24,857 | -19,004 | -11,184 |